MOTS-C

🧬 MOTS-C

Overview

MOTS-C is a naturally occurring mitochondrial-derived peptide involved in cellular energy regulation. It is being studied for its potential role in improving metabolic health, exercise capacity, and the body’s ability to adapt to changing energy demands.

Potential Benefits
⚡ Supports cellular energy production
🔥 Improves metabolic flexibility (fat and carbohydrate utilisation)
🩸 Supports healthy blood glucose regulation
🏃 May enhance endurance and exercise performance
💪 Supports recovery from physical activity
🧬 Promotes mitochondrial health and function
⚖️ May support healthy body composition when combined with nutrition and exercise

Proposed Mechanism

MOTS-C is thought to activate AMP-activated protein kinase (AMPK), a key regulator of cellular energy balance. This may help improve glucose utilisation, increase fatty acid oxidation, and enhance mitochondrial adaptation during periods of metabolic stress.

Common Research Dosing

Note: There is currently no approved human dosing regimen.

Commonly reported research protocols:
5–15 mg per week
Often divided into 2–3 injections per week
Typical research duration: 4–8 weeks
May be followed by a 2–4 week break

Commonly Stacked With
Retatrutide
SS-31
NAD+
5-Amino-1MQ
Resistance training
Cardiovascular exercise

Potential Side Effects

Reported effects vary and are based largely on anecdotal experience and limited human research.

Possible effects include:
Injection-site redness or swelling
Temporary flushing or warmth
Mild fatigue during the first few doses
Headache
Nausea (uncommon)
Histamine-like reactions in susceptible individuals

Best Suited For
✅ Metabolic optimisation
✅ Exercise performance
✅ Endurance support
✅ Recovery protocols
✅ Body recomposition programmes

Storage:

Before reconstitution
Refrigerate (2–8°C) for short-term storage
Freeze (−20°C) for long-term storage

After reconstitution
Store refrigerated (2–8°C)
Avoid repeated freeze–thaw cycles

Research Status

MOTS-C is an investigational peptide. While early human studies and preclinical research are promising, larger clinical trials are needed to confirm its long-term safety and effectiveness.
Lab test